Cargando…
In vivo molecular targeted radiotherapy
Unsealed radionuclides have been in clinical therapeutic use for well over half a century. Following the early inappropriate clinical administrations of radium salts in the early 20th century, the first real clinical benefits became evident with the use of (131)I-sodium iodide for the treatment of h...
Autor principal: | Perkins, AC |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097596/ https://www.ncbi.nlm.nih.gov/pubmed/21625282 http://dx.doi.org/10.2349/biij.1.2.e9 |
Ejemplares similares
-
Targeting the Tumour: Cell Penetrating Peptides for Molecular Imaging and Radiotherapy
por: Kersemans, Veerle, et al.
Publicado: (2010) -
Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy
por: Mortensen, A. C. L., et al.
Publicado: (2023) -
Radiation Oncology In Vitro: Trends to Improve Radiotherapy through Molecular Targets
por: Feofanova, Natália, et al.
Publicado: (2014) -
Evolution of Portable Sensors for In-Vivo Dose and Time-Activity Curve Monitoring as Tools for Personalized Dosimetry in Molecular Radiotherapy
por: Strigari, Lidia, et al.
Publicado: (2023) -
Molecular mechanisms of tumor resistance to radiotherapy
por: Wu, Yu, et al.
Publicado: (2023)